Clinical trials
Oncology clinical trials
Below are recruiting oncology clinical trials, each written for real people, not researchers. We’re tracking 798 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06081517Recruiting
Study of fairness in genetic cancer testing
This study looks at how well precision medicine (treatments based on your tumor's genes) is used for people with cancer. Researchers want to see if there are differences in who gets this kind of testing and treatment, so they can make it more fair for everyone.
Indianapolis, IndianaAges 18 years+ - NCT06087614RecruitingPhase 2
Higher-dose radiation for head and neck cancer
This trial tests a higher dose of radiation therapy that is adjusted based on oxygen levels in the tumor. It may help people with certain head and neck cancers that have not been treated before.
DelhiAges 18–70 - NCT06090669RecruitingPhase 1
Trial of imatinib for people with RUNX1 deficiency
This trial tests if imatinib can help people with a genetic condition called RUNX1 deficiency, which causes bleeding problems. It aims to increase the activity of the RUNX1 gene to improve blood clotting.
Bethesda, MarylandAges 18–120 - NCT06100237RecruitingPhase 2
Teclistamab and daratumumab for high-risk smoldering myeloma
This trial tests two immunotherapy drugs (teclistamab and daratumumab) for people with high-risk smoldering myeloma to see if the combination can stop or delay progression to active multiple myeloma. It's a new approach for those whose smoldering myeloma has a higher chance of becoming active.
Miami, FloridaAges 18 years+ - NCT06274268Recruiting
Sarcopenia and cancer treatment side effects study
This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.
ChambéryAges 18 years+ - NCT06117384Recruiting
Personalized ovarian cancer treatment study
This study aims to use your tumor and blood samples to find the best treatment for your ovarian cancer. It may help tailor your care based on your unique cancer biology.
HelsinkiAges Any age - NCT06140719Recruiting
Study to speed up DIPG and DMG research
This trial collects information from people with a rare type of brain tumor called DIPG or DMG. The goal is to help researchers learn more about these tumors and find better treatments faster.
Los Altos, CaliforniaAges Any age - NCT06156800Recruiting
Radiation before biopsy in advanced cancer
This trial tests whether it is safe and effective to start radiation therapy before getting a tissue biopsy for patients with advanced or metastatic cancer that needs urgent treatment. It aims to avoid delays in care while still allowing for a biopsy later.
London, OntarioAges 18 years+ - NCT06187870Recruiting
Biobank for urological and cancer research
This study collects blood, urine, and tissue samples from patients with urological diseases or cancers to build a biobank for future research. It may help researchers better understand these conditions and develop new treatments.
Milan, LombardyAges 18 years+ - NCT06193083Recruiting
Deprescribing views of patients with advanced cancer
This study asks patients with advanced cancer about their thoughts on stopping medications that may no longer be needed or could be harmful. It aims to understand patient perspectives to improve care.
La Roche-sur-YonAges 18 years+ - NCT06198842RecruitingPhase 2
Low-dose treosulfan with PTCy for Nijmegen Breakage Syndrome transplant
This trial tests a low-dose chemotherapy regimen (treosulfan) combined with a drug called PTCy to prepare children with Nijmegen Breakage Syndrome for a stem cell transplant. The goal is to reduce side effects while helping the donor cells take hold safely.
MoscowAges 3 months–21 years - NCT06201884RecruitingPhase 2
Walking program for older patients after cancer surgery
This study tests whether a special walking program (using a platform) can help older patients recover better after cancer surgery. If you are 65 or older and can walk on the platform for 10 minutes, you might be eligible.
CaenAges 65 years+ - NCT06207032Recruiting
Cancer biobank registry study
This study collects blood samples and health information from people diagnosed with cancer to build a research database. It may help future patients by enabling better understanding and treatment of cancer.
Birmingham, AlabamaAges 18–99 - NCT06219083Recruiting
Nutrition and outcomes in common cancers
This study looks at how nutrition affects recovery and results in people getting chemotherapy or radiation for common cancers. It may help improve care by tracking what you eat and how your body responds.
Xi'an, ShaanxiAges 18 years+ - NCT06222801Recruiting
Cytokinetic therapy study for adults with cancer
This study collects information from people with cancer who receive a special treatment called cytogenetic therapy, which uses your own cells to attack the tumor. The goal is to learn more about this treatment and its results.
MoscowAges 18–95 - NCT06226857RecruitingPhase 3
Anti-EGFR for left-sided, RAS wild-type metastatic colorectal cancer
This trial tests whether anti-EGFR therapy works better for people with left-sided colorectal cancer that has spread, whose tumors do not have certain gene mutations (RAS wild-type). It is for those who have not yet had treatment for metastatic disease.
MoscowAges 18–99 - NCT06229340RecruitingPhase 2
Two drug combinations for advanced cancer with RAS mutations
This trial tests two different treatment combinations (leflunomide alone or with MEK inhibitor and hydroxychloroquine) in people with advanced cancer that has a RAS mutation and has not responded to at least two prior therapies.
Saint PetersburgAges 18–85 - NCT06247787RecruitingPhase 1
Imetelstat plus chemo for relapsed leukemia in kids
This trial tests a new drug called imetelstat combined with two chemotherapy drugs (fludarabine and cytarabine) for children and teens with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or juvenile myelomonocytic leukemia (JMML) that has come back or not responded to treatment. The goal is to find the safest dose of imetelstat and see if it helps control the cancer.
Birmingham, AlabamaAges 1–18 - NCT06253611RecruitingPhase 2
Probiotic plus immunotherapy and chemo for stomach cancer
This trial tests a new combination for advanced stomach cancer: an experimental probiotic (EXL01) plus standard immunotherapy (nivolumab) and chemotherapy (FOLFOX). It is for people whose tumors have a high PD-L1 marker and who have not received prior treatment for advanced disease.
AngersAges 18 years+ - NCT06270017RecruitingPhase 1/Phase 2
Zebrafish Avatars for Colon Cancer Treatment
This trial uses tiny zebrafish to grow a piece of your tumor and test which treatments might work best for you. It is for patients with colon cancer who are scheduled for surgery to remove their tumor.
Linköping, Östergötland CountyAges 18 years+ - NCT06270602Recruiting
Cancer information collection study
This study is using the ROC platform to collect information about people with cancer. It may help researchers learn more about cancer care.
Avellino, AvellinoAges 18 years+ - NCT06279260Recruiting
National robotic prostate surgery database study
This study collects health information from men who have had robotic surgery for prostate cancer. It aims to learn more about the outcomes of this surgery to help improve future care.
Ballarat, VictoriaAges 18–90 - NCT06279442Recruiting
Study of adrenocortical cancer in a Brazilian group
This study looks at patients with adrenocortical carcinoma, a rare type of adrenal gland cancer, to learn more about the disease and how it affects people in Brazil. You may join if you were diagnosed or had a recurrence in 2000 or later and have had a clinic visit at the participating hospital.
Fortaleza, CearáAges 18 years+ - NCT06281210Recruiting
Test to skip breast surgery after chemo
This trial checks if a breast biopsy can confirm that chemo has destroyed all cancer cells, so you might avoid surgery altogether. It's for people with aggressive breast cancer types who responded well to chemotherapy.
Candiolo, TurinAges 18 years+
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for oncology?
- Yes. Clin2 currently lists 798 recruiting oncology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a oncology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a oncology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.